Delivery Order SPE2DB24D9238-SPE2DB24FDQMV

Award Date 8/23/24
Potential Completion Date 9/16/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,717.52 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Nexplanon 68 mg implants to support the medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,720.35, is for the delivery of Nexplanon 68 mg implants with a performance period through July 3, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Nexplanon 68 mg implants, a contraceptive product, with a ceiling value of $28,587.60 and a completion date of May 20, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which allows...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of Nexplanon 68 mg implants. The award has a ceiling value of $8,576.28 and a period of performance through July 8, 2024. This delivery order is part of a larger indefinite delivery contract (SPE2DB) held by DMS Pharmaceutical Group with the DLA, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Nexplanon 68 mg implants, with a ceiling value of $7,146.90 and a period of performance through February 20, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Nexplanon 68 mg implants, with a ceiling value of $7,146.90 and a period of performance through July 30, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $77,901.21 contract is for the delivery of Nexplanon 68 mg implants to support the recurring medical supply needs of military health facilities. The delivery order was issued under a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $42,881.40 and covers the delivery of Nexplanon (68 mg) contraceptive implants. This delivery order is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,837.40, is for the delivery of 4,562,331,276 Nexplanon 68 mg implants. This delivery order is issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which allows the DLA to order a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,720.35 contract is for the delivery of 4,565,067,184 Nexplanon 68 mg implants. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the agency to issue delivery orders for a...
  • SPE2DB24D9238
    Indefinite Delivery Contract
  • SPE2DB24D9238-SPE2DB24FDQMV
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the procurement of Nexplanon 68 mg implants, with a ceiling value of $10,720.35 and a period of performance through September 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide array of medications and medical supplies to the Department of Defense and Department of Veterans Affairs.

Generated 11/22/24, 9:48 AM